CHEK2 and breast cancer: A population-based study found that deletion in CHEK2 (CHEK2*1100delC) is present at a frequency of 1.1% in controls, 5.1% in cases with a family history, and 13.5% in cases with a family history of male BC in a population with a positive history of BC but no BRCA mutation [59].